Original Literature | Model OverView |
---|---|
Publication
Title
The role of type I interferon production by dendritic cells in host defense.
Affiliation
UMDNJ-New Jersey Medical School, 185 So. Orange Ave., Newark, NJ 07103, USA.bocarsly@umdnj.edu
Abstract
Type I interferons (IFN) and dendritic cells (DC) share an overlapping history,with rapidly accumulating evidence for vital roles for both production of type 1IFN by DC and the interaction of this IFN both with DC and components of theinnate and adaptive immune responses. Within the innate immune response, theplasmacytoid DC (pDC) are the "professional" IFN producing cells, expressingspecialized toll-like receptors (TLR7 and -9) and high constitutive expressionof IRF-7 that allow them to respond to viruses with rapid and extremely robustIFN production; following activation and production of IFN, the pDC subsequentlymature into antigen presenting cells that help to shape the adaptive immuneresponse. However, like most cells in the body, the myeloid or conventional DC(mDC or cDC) also produce type I IFNs, albeit typically at a lower level thanthat observed with pDC, and this IFN is also important in innate and adaptiveimmunity induced by these classic antigen presenting cells. These two major DCsubsets and their IFN products interact both with each other as well as with NKcells, monocytes, T helper cells, T cytotoxic cells, T regulatory cells and Bcells to orchestrate the early immune response. This review discusses some ofthe converging history of DC and IFN as well as mechanisms for IFN induction inDC and the effects of this IFN on the developing immune response.
PMID
17544561
|
Entity
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
TLR9:CpG DNA
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
csml-variable:Double
m14
0
infinite
0
--
TLR9:ds DNA
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
Imidazoquinolones
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
TLR7:Imidazoquinolones
--
e17
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m17
0
infinite
0
--
csml-variable:Double
m18
0
infinite
0
--
TLR7:ssRNA
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TLR9:CpG DNA:MyD88
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
TLR7:ssRNA:MyD99
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
TLR9:CpG DNA: MyD88:IRAK-1:IRAK-4:TRAF6{ub}
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
TLR7:ssRNA: MyD88:IRAK-1:IRAK-4:TRAF6
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
TLR7:ssRNA: MyD88:IRAK-1:IRAK-4:TRAF6{ub}
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
TLR9:CpG DNA: MyD88:IRAK-1:IRAK-4:TRAF6
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
TLR9:CpG DNA:MyD88:IRAK-1:IRAK-4:TRAF6{ub}:IRF-7
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
TLR7:ssRNA: MyD88:IRAK-1:IRAK-4:TRAF6{ub}:IRF-7
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
TLR7:ssRNA: MyD88:IRAK-1:IRAK-4:TRAF6{ub}:IRF-7{p}
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TLR9:CpG DNA:MyD88:IRAK-1:IRAK-4:TRAF6{ub}:IRF-7{p}
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
Type I IFN
--
e31
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m31
0
infinite
0
--
DDX58:dsRNA
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
IFIH1:dsRNA
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
DDX58:dsRNA:MAVS
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
IFIH1:dsRNA:MAVS
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
DDX58:dsRNA:MAVS:TBK1:IKK-i
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
TBK1:IKK-i
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
DDX58:dsRNA:MAVS:TBK1:IKK-i
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
Type I IFNs
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
IFNalpha/beta R
--
e43
cso30:c:Protein
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m43
0
infinite
0
--
Type I IFNs
--
e44
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m44
0
infinite
0
--
csml-variable:Double
m45
0
infinite
0
--
ISGF3{active}
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
C-type lectin receptor
--
e47
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m47
0
infinite
0
--
gD
--
e48
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m48
0
infinite
0
--
gD:C-type Lectin receptor
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
gp120
--
e63
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m63
0
infinite
0
--
gp120:C-type Lectin receptor
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
IFN-alpha
--
e65
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m65
0
infinite
0
--
Ligand:ILT7
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
FcepsilonR1gamma
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
FcepsilonR1gamma
--
e68
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
Cytokines
--
e69
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IFN-alpha
--
e70
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
IP-10
--
e71
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m71
0
infinite
0
--
Trail
--
e72
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m72
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c6 : 1
m19828*m12*0.1
nodelay
--
0
PMID: 17544561,12900525,15272082,15345224,12470615,15113904,14976261,16224540,15034168 TLR9 is the receptor for both CpG sequences and double-stranded DNA from herpes simplex virus and cytomegalovirus, while the ligands for TLR7 include the imadazoquinolones and single stranded RNA such as found in viruses like HIV-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m23*0.1
nodelay
--
0
PMID: 17544561,16286015,15361868,15492225 This association, which requires that the TLR and ligand remain for an extended time in the endosome as opposed to being transferred to the lysosome for induction of IFN, also requires IRAK-4 and the ubiquitin ligase action of TRAF6 for the activation of IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m23*m980*0.1
nodelay
--
0
PMID: 17544561, 15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m980*m25*0.1
nodelay
--
0
PMID: 17544561, 15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m28*0.1
nodelay
--
0
PMID: 17544561, 15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m27*0.1
nodelay
--
0
PMID: 17544561, 15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c108 : 1
stoichiometry:c44 : 1
m30*0.1
nodelay
--
0
PMID: 17544561, 15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN PMID: 17544561, 15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC PMID: 17544561 These IFNs are translated, then secreted, and signal through the IFN-alpha/beta receptor and, through ISGF3 (comprised of STAT1, STAT2 and IRF-9), upregulate IRF-7 expression which is needed for the expression of the full range and magnitude of the IFN-alpha genes. PMID: 17544561 They further reported that cross-linking of this receptor on the pDC inhibits CpG and Flu-induced type I IFN and cytokine expression by these cells.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m3965*m119368*0.1
nodelay
--
0
PMID: 17544561 cDC have an additional mechanism for the induction of type I IFN in response to dsRNA viruses that goes via the dsRNA sensor, TLR3 in the endosomes.
p17
p17
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m18998*m19314*0.1
nodelay
--
0
PMID: 17544561,15711573 TLR3 signaling utilizes the adaptor molecule TRIF rather than the IPS-1/MAV5 used in the RIG-I/MDA-5 pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m32*m41844*0.1
nodelay
--
0
PMID: 17544561,16210631,15208624 dsRNA is well-known for its ability to activate PKR, but, more recently, the role for the retinoic acid-inducible gene-I (RIG-I) encoded helicases and melanoma differentiation-associated gene 5 (MDA-5) have been strongly implicated as the prevalent cytoplasmic receptors for dsRNA leading to IFN-alpha production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m76904*m32*0.1
nodelay
--
0
PMID: 17544561,16210631,15208624 dsRNA is well-known for its ability to activate PKR, but, more recently, the role for the retinoic acid-inducible gene-I (RIG-I) encoded helicases and melanoma differentiation-associated gene 5 (MDA-5) have been strongly implicated as the prevalent cytoplasmic receptors for dsRNA leading to IFN-alpha production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m14*m19828*0.1
nodelay
--
0
PMID: 17544561,12900525,15272082,15345224,12470615,15113904,14976261,16224540,15034168 TLR9 is the receptor for both CpG sequences and double-stranded DNA from herpes simplex virus and cytomegalovirus, while the ligands for TLR7 include the imadazoquinolones and single stranded RNA such as found in viruses like HIV-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m68199*m33*0.1
nodelay
--
0
PMID: 17544561 Figure 1 PMID: 17544561, 15711573 TLR3 signaling utilizes the adaptor molecule TRIF rather than the IPS-1/MAV5 used in the RIG-I/MDA-5 pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m34*m68199*0.1
nodelay
--
0
PMID: 17544561 Figure 1 PMID: 17544561, 15711573 TLR3 signaling utilizes the adaptor molecule TRIF rather than the IPS-1/MAV5 used in the RIG-I/MDA-5 pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
1.0*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c67 : 1
m38*m35*0.1
nodelay
--
0
PMID: 17544561 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c68 : 1
m36*m38*0.1
nodelay
--
0
PMID: 17544561 Figure 1
p25
p25
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m37*m977*0.1
nodelay
--
0
PMID: 17544561 Figure 1
p25
p26
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m39*m977*0.1
nodelay
--
0
PMID: 17544561 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c76 : 1
m41*0.1
nodelay
--
0
PMID: 17544561 Figure 1 PMID: 17544561, 16210631, 15208624 dsRNA is well-known for its ability to activate PKR, but, more recently, the role for the retinoic acid-inducible gene-I (RIG-I) encoded helicases and melanoma differentiation-associated gene 5 (MDA-5) have been strongly implicated as the prevalent cytoplasmic receptors for dsRNA leading to IFN-alpha production PMID: 17544561 cDC have an additional mechanism for the induction of type I IFN in response to dsRNA viruses that goes via the dsRNA sensor, TLR3 in the endosomes
p28
p28
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m155666*0.1
nodelay
--
0
PMID: 17544561,15265881 our group demonstrated that human peripheral blood pDC express basal levels of TLR4 and respond to LPS stimulation with upregulation of TLR4 message and protein as well as up-regulate the expression of the transcription factor, IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m93614*0.1
nodelay
--
0
PMID: 17544561,15265881 our group demonstrated that human peripheral blood pDC express basal levels of TLR4 and respond to LPS stimulation with upregulation of TLR4 message and protein as well as up-regulate the expression of the transcription factor, IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m19940*m16*0.1
nodelay
--
0
PMID: 17544561,12900525,15272082,15345224,12470615,15113904,14976261,16224540,15034168 TLR9 is the receptor for both CpG sequences and double-stranded DNA from herpes simplex virus and cytomegalovirus, while the ligands for TLR7 include the imadazoquinolones and single stranded RNA such as found in viruses like HIV-1
p28
p30
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m155666*0.1
nodelay
--
0
PMID: 17544561,15265881 our group demonstrated that human peripheral blood pDC express basal levels of TLR4 and respond to LPS stimulation with upregulation of TLR4 message and protein as well as up-regulate the expression of the transcription factor, IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c83 : 1
m40*0.1
nodelay
--
0
PMID: 17544561 According to the classic pathway of type I IFN induction, virus stimulation leads to the phosphorylation of IRF-3, its translocation to the nucleus and subsequent upregulation of a subset of early type I IFN genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m31*0.1
nodelay
--
0
PMID: 17544561 These IFNs are translated, then secreted, and signal through the IFN-alpha/beta receptor and, through ISGF3 (comprised of STAT1, STAT2 and IRF-9), upregulate IRF-7 expression which is needed for the expression of the full range and magnitude of the IFN-alpha genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m42*m43*0.1
nodelay
--
0
PMID: 17544561 These IFNs are translated, then secreted, and signal through the IFN-alpha/beta receptor and, through ISGF3 (comprised of STAT1, STAT2 and IRF-9), upregulate IRF-7 expression which is needed for the expression of the full range and magnitude of the IFN-alpha genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m44*m45*0.1
nodelay
--
0
PMID: 17544561 These IFNs are translated, then secreted, and signal through the IFN-alpha/beta receptor and, through ISGF3 (comprised of STAT1, STAT2 and IRF-9), upregulate IRF-7 expression which is needed for the expression of the full range and magnitude of the IFN-alpha genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m46*0.1
nodelay
--
0
PMID: 17544561 These IFNs are translated, then secreted, and signal through the IFN-alpha/beta receptor and, through ISGF3 (comprised of STAT1, STAT2 and IRF-9), upregulate IRF-7 expression which is needed for the expression of the full range and magnitude of the IFN-alpha genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m48*m47*0.1
nodelay
--
0
PMID: 17544561 Proposed candidate receptors for these viral glycoproteins are C-type lectin receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m47*m63*0.1
nodelay
--
0
PMID: 17544561 Proposed candidate receptors for these viral glycoproteins are C-type lectin receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m49*0.1
nodelay
--
0
PMID: 17544561,9837796,2999320,1850168,7526537, 7908920 In pDC, a requirement for viral envelope glycosylation in IFN-alpha induction, presumably by interaction of the glycoproteins with cell surface receptors, has been demonstrated. Examples of this include the requirement for gD, a glycoprotein of HSV-1 required for viral entry for induction of IFN-alpha in pDC and the mutation of a single amino acid in the M protein of porcine transmissible gastroenteritis virus that renders the virus non-interferogenic and the dependence on gp120 of HIV for IFN induction by pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m64*0.1
nodelay
--
0
PMID: 17544561,9837796,2999320,1850168,7526537, 7908920 In pDC, a requirement for viral envelope glycosylation in IFN-alpha induction, presumably by interaction of the glycoproteins with cell surface receptors, has been demonstrated. Examples of this include the requirement for gD, a glycoprotein of HSV-1 required for viral entry for induction of IFN-alpha in pDC and the mutation of a single amino acid in the M protein of porcine transmissible gastroenteritis virus that renders the virus non-interferogenic and the dependence on gp120 of HIV for IFN induction by pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m18*m19940*0.1
nodelay
--
0
PMID: 17544561,12900525,15272082,15345224,12470615,15113904,14976261,16224540,15034168 TLR9 is the receptor for both CpG sequences and double-stranded DNA from herpes simplex virus and cytomegalovirus, while the ligands for TLR7 include the imadazoquinolones and single stranded RNA such as found in viruses like HIV-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m67*m66*0.1
nodelay
--
0
PMID: 17544561,16735691 Cao et al. have recently described the expression of the ILT7 receptor on human pDC and demonstrated that it associates with the signal adapter protein Fc¦ÅR1¦Ã to form a receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m29*0.1
nodelay
--
0
PMID: 17544561, 15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN PMID: 17544561, 15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c113 : 1
stoichiometry:c112 : 1
m30*0.1
nodelay
--
0
PMID: 17544561 They further reported that cross-linking of this receptor on the pDC inhibits CpG and Flu-induced type I IFN and cytokine expression by these cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m70*0.1
nodelay
--
0
PMID: 17544561 In our study, we demonstrated that IFN-¦Á of PBMC can lead to direct upregulation of CXCL10 in pDC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m70*0.1
nodelay
--
0
PMID: 17544561,17116765 Such activation of CD8+ cells is not always advantageous; for example, it has recently been demonstrated that pDC derived IFN-¦Á can stimulate cytotoxic T cell activity in atherosclerotic plaque through the induction of TRAIL
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m13*m1572*0.1
nodelay
--
0
PMID: 17544561,15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m1572*m19*0.1
nodelay
--
0
PMID: 17544561,15815647 MyD88, which is required for signaling through TLR7 and TLR9, forms a complex with IRF-7 that is required for the signaling for type I IFN production in the pDC
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m20*m183*m17258*m22*0.1
nodelay
--
0
PMID: 17544561,16286015,15361868,15492225 This association, which requires that the TLR and ligand remain for an extended time in the endosome as opposed to being transferred to the lysosome for induction of IFN, also requires IRAK-4 and the ubiquitin ligase action of TRAF6 for the activation of IRF-7 PMID: 17544561,15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN
p7
p8
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m22*m17258*m183*m21*0.1
nodelay
--
0
PMID: 17544561,16286015,15361868,15492225 This association, which requires that the TLR and ligand remain for an extended time in the endosome as opposed to being transferred to the lysosome for induction of IFN, also requires IRAK-4 and the ubiquitin ligase action of TRAF6 for the activation of IRF-7 PMID: 17544561,15767370 A recent study demonstrated that the kinase that interacts with and phosphorylates the IRF-7 is IRAK-1; IRAK-1 deficient mice were found to be severely compromised in their ability to activate IRF-7 and induce type 1 IFN
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m24*0.1
nodelay
--
0
PMID: 17544561,16286015,15361868,15492225 This association, which requires that the TLR and ligand remain for an extended time in the endosome as opposed to being transferred to the lysosome for induction of IFN, also requires IRAK-4 and the ubiquitin ligase action of TRAF6 for the activation of IRF-7
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--